Do neutrophil-lymphocyte ratio and platelet-lymphocyte ratio have a role in determining mortality in intensive care patients undergoing plasmapheresis? Single-center experience

dc.authorid0000-0002-6315-9620
dc.authorid0000-0001-8914-7911
dc.authorid0000-0002-0383-7792
dc.contributor.authorSadri, Sevil
dc.contributor.authorÇavuşoğlu, Güneş
dc.contributor.authorTunay, Burcu
dc.date.accessioned2023-09-21T08:29:25Z
dc.date.available2023-09-21T08:29:25Z
dc.date.issued2023
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Anesteziyoloji ve Reanimasyon Ana Bilim Dalı
dc.description.abstractIntroduction: Plasmapheresis is a frequently used procedure that removes the pathogenic components from circulation. We aimed to evaluate the relationship between plasmapheresis, neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR) and mortality in the intensive care unit (ICU) between 2014 and 2021. Methods: Forty-nine patients (27 females and 22 males) were included. Demographic characteristics, laboratory values of the day of admittance to the ICU, APACHE II scores, and length of stay were recorded. Results: The mean age was 52.73 ± 16.93. APACHE II value (p = 0.003; p < 0.01), NLR ratio (p = 0.001; p < 0.01) and PLR ratio (p = 0.001; p < 0.01) of the surviving group were lower than those of the deceased group, which was statistically significant. Conclusion: As high PLR and NLR levels suggest increased mortality in the ICU population, attention should be paid for increased NLR and PLR when plasmapheresis is decided on in the ICU.
dc.identifier.citationSadri, S., Çavuşoğlu, G. ve Tunay, B. (2023). Do neutrophil-lymphocyte ratio and platelet-lymphocyte ratio have a role in determining mortality in intensive care patients undergoing plasmapheresis? Single-center experience. Therapeutic Apheresis and Dialysis, 27(1), 146-151. https://doi.org/10.1111/1744-9987.13900
dc.identifier.doi10.1111/1744-9987.13900
dc.identifier.endpage151
dc.identifier.issn1744-9979
dc.identifier.issn1744-9987
dc.identifier.issue1
dc.identifier.pmid35730341
dc.identifier.scopus2-s2.0-85133345905
dc.identifier.scopusqualityQ2
dc.identifier.startpage146
dc.identifier.urihttps://doi.org/10.1111/1744-9987.13900
dc.identifier.urihttps://hdl.handle.net/20.500.12511/11478
dc.identifier.volume27
dc.identifier.wos000820495900001en_US
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorSadri, Sevil
dc.institutionauthorÇavuşoğlu, Güneş
dc.institutionauthorTunay, Burcu
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofTherapeutic Apheresis and Dialysisen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectNeutrophil to Lymphocyte Ratio
dc.subjectPlasmapheresis
dc.subjectPlatelet to Lymphocyte Ratio
dc.titleDo neutrophil-lymphocyte ratio and platelet-lymphocyte ratio have a role in determining mortality in intensive care patients undergoing plasmapheresis? Single-center experience
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Sadri-Sevil-2023.pdf
Boyut:
576.98 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: